McCloy R F, Dawson V A, Baron J H
Acta Hepatogastroenterol (Stuttg). 1979 Oct;26(5):399-406.
The beta 2 adrenergic agonist Salbutamol was infused intravenously in doses of 0.05, 0.1 and 0.2 microgram/kg-min in conscious dogs with gastric fistulae. Salbutamol inhibited meal-stimulated acid (measured with intragastric titration) by up to 82%. Salbutamol produced dose-related inhibition of acid stimulated by pentagastrin (up to 88%) and by histamine (up to 52%). Pepsin secretion in response to histamine (but not pentagastrin) was also inhibited by salbutamol. The salbutamol infusion caused a marked tachycardia, an increase in pulse pressure, slight hyperkalaemia and hyperglycaemia. The beta-adrenergic antagonist propranolol augmented pentagastrin-stimulated acid and inhibited meal-stimulated secretion. Propranolol abolished salbutamol - induced tachycardia, and blocked the inhibition by salbutamol of pentagastrin-stimulated acid. Salbutamol inhibition of acid in the dog provides further support for the hypothesis that there are beta 2-adrenergic receptors in the stomach.
将β2肾上腺素能激动剂沙丁胺醇以0.05、0.1和0.2微克/千克·分钟的剂量静脉注射到有胃瘘的清醒犬体内。沙丁胺醇可使进食刺激的胃酸分泌(通过胃内滴定法测量)抑制高达82%。沙丁胺醇对五肽胃泌素刺激的胃酸分泌(抑制高达88%)和组胺刺激的胃酸分泌(抑制高达52%)产生剂量依赖性抑制作用。沙丁胺醇还可抑制组胺(而非五肽胃泌素)刺激引起的胃蛋白酶分泌。静脉输注沙丁胺醇会导致明显的心动过速、脉压升高、轻度高钾血症和高血糖症。β肾上腺素能拮抗剂普萘洛尔可增强五肽胃泌素刺激的胃酸分泌,并抑制进食刺激的胃酸分泌。普萘洛尔可消除沙丁胺醇引起的心动过速,并阻断沙丁胺醇对五肽胃泌素刺激的胃酸分泌的抑制作用。沙丁胺醇对犬胃酸分泌的抑制作用为胃中存在β2肾上腺素能受体这一假说提供了进一步支持。